We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNGE
451
Hinge Health
HNGE
$5.93B
$4.24M 0.02%
110,088
+1,833
+2% +$76.2K
MMI icon
452
Marcus & Millichap
MMI
$1.13B
$4.24M 0.02%
159,619
+85,535
+115% +$2.25M
TRDA icon
453
Entrada Therapeutics
TRDA
$235M
$4.21M 0.02%
333,914
-28,872
-8% -$331K
ASPN icon
454
Aspen Aerogels
ASPN
$428M
$4.17M 0.02%
1,218,779
+1,078,666
+770% +$3.64M
KRMN
455
Karman Holdings
KRMN
$6.59B
$4.16M 0.02%
+51,918
New +$5.01M
PLTK icon
456
Playtika
PLTK
$1.36B
$4.13M 0.02%
1,487,287
+1,458,110
+4,997% +$4.78M
GRNT icon
457
Granite Ridge Resources
GRNT
$650M
$4.12M 0.02%
702,319
+125,366
+22% +$629K
OSG
458
Octave Specialty Group
OSG
$249M
$4.11M 0.02%
884,272
+647,087
+273% +$3.7M
LGND icon
459
Ligand Pharmaceuticals
LGND
$6.06B
$4.1M 0.02%
20,529
-106,225
-84% -$21M
ARKO icon
460
ARKO Corp
ARKO
$895M
$4.09M 0.02%
734,899
+435,229
+145% +$2.43M
KBH icon
461
KB Home
KBH
$3.41B
$4.07M 0.02%
78,733
-134,590
-63% -$7.92M
CLW icon
462
Clearwater Paper
CLW
$264M
$4.04M 0.02%
281,048
-1,160
-0.4% -$18.9K
MTRX icon
463
Matrix Service
MTRX
$361M
$4.03M 0.02%
350,987
+24,754
+8% +$295K
OCUL icon
464
Ocular Therapeutix
OCUL
$1.89B
$3.98M 0.02%
470,029
+176,766
+60% +$1.68M
NABL icon
465
N-able
NABL
$733M
$3.97M 0.02%
849,220
+345,969
+69% +$1.93M
MLAB icon
466
Mesa Laboratories
MLAB
$558M
$3.93M 0.02%
44,417
+5,575
+14% +$480K
PTON icon
467
Peloton Interactive
PTON
$2.61B
$3.92M 0.02%
913,604
-131,266
-13% -$640K
CR icon
468
Crane Co
CR
$12.6B
$3.87M 0.02%
+22,635
New +$4.35M
UFCS icon
469
United Fire Group
UFCS
$1.27B
$3.87M 0.02%
104,414
+2,009
+2% +$74.1K
ROP icon
470
Roper Technologies
ROP
$35.8B
$3.85M 0.02%
+10,894
New +$4.02M
ANIK icon
471
Anika Therapeutics
ANIK
$195M
$3.85M 0.02%
265,627
+70,042
+36% +$813K
RPD icon
472
Rapid7
RPD
$639M
$3.81M 0.02%
692,301
-502,927
-42% -$4.62M
BALL icon
473
Ball Corp
BALL
$16.6B
$3.79M 0.02%
64,083
-354,524
-85% -$21.6M
BY icon
474
Byline Bancorp
BY
$1.71B
$3.72M 0.02%
117,845
+6,224
+6% +$195K
HVT icon
475
Haverty Furniture Companies
HVT
$398M
$3.7M 0.02%
174,840
-19,336
-10% -$471K

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.